Biocon gets USFDA nod for generic product

Biotechnology major Biocon on Thursday said its unit has received approval from the US health regulator to market a generic product.

Biocon Pharma, a subsidiary of the company, has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Mycophenolic Acid, the company said in a regulatory filing.

The product is indicated for the prophylaxis of organ rejection in adult patients receiving a kidney transplant and is available in 180mg and 360mg strengths.

This approval further adds to Biocon’s portfolio of vertically integrated complex drug products, the company noted.

  • Related Posts

    Probe report into maternal deaths sparks Kota row

    Rajasthan Health Minister Gajendra Singh Khinvsar confirmed that government has received the report and is conducting a review JAIPUR: The report of the probe into the deaths of five pregnant women…

    Centre bans 16 Fixed-Dose Combination drugs over safety concerns

    The Centre has imposed an immediate ban on 16 Fixed Dose Combination (FDC) drugs. The Ministry of Health and Family Welfare issued the orders under Section 26A of the Drugs…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Probe report into maternal deaths sparks Kota row

    Probe report into maternal deaths sparks Kota row

    Centre bans 16 Fixed-Dose Combination drugs over safety concerns

    Centre bans 16 Fixed-Dose Combination drugs over safety concerns

    Maha FDA seizes medicines worth Rs 9.09 lakh from Mumbai children’s hospital over alleged illegal sale

    Maha FDA seizes medicines worth Rs 9.09 lakh from Mumbai children’s hospital over alleged illegal sale

    CDSCO constitutes consultancy committee for advice on suo motu disclosure

    CDSCO constitutes consultancy committee for advice on suo motu disclosure

    Telangana DCA busts illegal API stock, seizes drugs worth Rs 34L

    Telangana DCA busts illegal API stock, seizes drugs worth Rs 34L

    Zenré Wellness, a New Genre of Mental Care, unveils in Delhi

    Zenré Wellness, a New Genre of Mental Care, unveils in Delhi